Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
FDA lifted clinical hold on ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS) Meeting with the FDA scheduled for the first quarter of 2027 to discuss the Company’s proposed clinical development plan for ARD-101; Company...
Super Hi to Report Third Quarter 2026 Financial Results on Wednesday, November 25, 2026
GlobeNewswire, Inc.
- Earnings Call Scheduled for 7:00 a.m. ET on November 25, 2026 SINGAPORE, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Super Hi International Holding Ltd. ("Super Hi" or the "Company") (NASDAQ: HDL and HKEX: 9658), a leading Chinese cuisine restaurant brand...
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
GlobeNewswire, Inc.
- Ended third quarter with $24.1 million in cash and restricted cash - Expects positive fourth quarter earnings between $0.01 and $0.04 per share TARPON SPRINGS, Fla., November 13, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”)...
GH Research Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Novel GH001 Aerosol Delivery System (ADS) device: final results of the GH001-HV-106 trial support going from 3 → 1 doses per treatment visit TRD pivotal program — positive initial feedback from FDA, End-of-Phase 2 meeting expected in Q1 2027,...
Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
GlobeNewswire, Inc.
Launch of CARDAMYST® (etripamil) nasal spray marked by steady prescription growth, new prescriber expansion and improving commercial coverage Company is reducing operating expenses by approximately 30% while prioritizing sales force efforts for...
North Texas Food Bank, UNT Dallas, Tom Thumb / Albertsons Join Forces for Thanksgiving Food Distribution
GlobeNewswire, Inc.
Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- The North Texas Food Bank (NTFB), the University of North Texas at Dallas (UNT Dallas), and Tom Thumb / Albertsons are partnering once again to support families facing hunger this holiday season.
Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
- FDA feedback expected in Q4 2026 on proposed use of new formulation of brilaroxazine in the RECOVER-2 trial and a future NDA submission - - U.S. patent office has granted priority examination (Track 1) for the composition of matter patent...
BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Alignment with the US Food and Drug Administration (FDA) on 50 mg twice daily as the recommended Phase 2 dose for BH-30643 based on favorable PK, safety, and efficacy data to date Announced SOLARA-2, the single-arm pivotal Phase 2 portion of the...
In-Depth Tegsedi Market Report Includes Forecasts, Innovations, and Industry Perspectives
EIN Presswire
The Business Research Company's Tegsedi Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 12, 2026 /EINPresswire.com/ -- "The Tegsedi market is experiencing noteworthy...
Sienna Reports Third Quarter 2026 Financial Results and Continues Platform Growth
GlobeNewswire, Inc.
MARKHAM, Ontario, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and nine months ended September 30, 2026. Highlights Average Same Property...
Innovative Food Holdings, Inc. Reports Financial Results for Third Quarter 2026
GlobeNewswire, Inc.
Key third-quarter results: Revenue of $12.0 million, down 23.8% from Q3 2025 GAAP net loss from continuing operations of $181 thousand, compared with net income of $651 thousand in Q3 2025 GAAP diluted EPS from continuing operations of $(0.003),...
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Planned global Phase 3 LEGACY trial of tegoprubart in kidney transplantation remains on track to initiate in Q4 2026 FDA cleared the Company’s IND application for a planned registrational path study of tegoprubart in islet cell transplantation for...
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
GlobeNewswire, Inc.
Azora Therapeutics commenced trading on Nasdaq as “AZR” New executive team and Board of Directors appointed AT177 IND submission and Phase 1a initiation on track for the first half of 2027 LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Azora...
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Jemperli global net sales of $1.0 billion (£753 million) for the nine months ended September 30, 2026, representing 29% year-over-year growth Jemperli approved in the U.S. as the first and only immunotherapy for adults with stage II and III...
Cibus Reports Third Quarter Financial Results and Provides Business Update
GlobeNewswire, Inc.
Rice herbicide-tolerance traits performed well in Latin American field trials and are now being tested by customer Interoc in its own varieties Initiated the manufacturing process for initial two biofragrance products; biofragrance program...
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
FREDERICK, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today...
InspireMD Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
- Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedures, expected to approximately double the U.S. addressable market - - Company to host investor conference call today, November 12th, at 4:30pm ET -...
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Application (BLA) for aglatimagene in prostate cancer.
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
GlobeNewswire, Inc.
REMAIN-1 Pivotal Cohort met its six-month co-primary endpoint with high statistical significance (p=0.0023); Revita® participants retained approximately 80% of GLP-1-induced weight loss versus 67% for sham Planned FDA De Novo submission in late Q4...
Erasca Reports Third Quarter 2026 Business Updates and Financial Results
GlobeNewswire, Inc.
ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Updated ERAS-0015 monotherapy and nonclinical ERAS-0015/ERAS-4001...
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.